555 related articles for article (PubMed ID: 25495520)
1. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
[TBL] [Abstract][Full Text] [Related]
2. Estradiol, but not dehydroepiandrosterone, decreases parasitemia and increases the incidence of cerebral malaria and the mortality in plasmodium berghei ANKA-infected CBA mice.
Libonati RM; Cunha MG; Souza JM; Santos MV; Oliveira SG; Daniel-Ribeiro CT; Carvalho LJ; do Nascimento JL
Neuroimmunomodulation; 2006; 13(1):28-35. PubMed ID: 16699290
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.
Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y
Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013
[TBL] [Abstract][Full Text] [Related]
4. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner.
Schmidt KE; Schumak B; Specht S; Dubben B; Limmer A; Hoerauf A
Microbes Infect; 2011 Sep; 13(10):828-36. PubMed ID: 21609776
[TBL] [Abstract][Full Text] [Related]
5. Schistosoma co-infection protects against brain pathology but does not prevent severe disease and death in a murine model of cerebral malaria.
Bucher K; Dietz K; Lackner P; Pasche B; Fendel R; Mordmüller B; Ben-Smith A; Hoffmann WH
Int J Parasitol; 2011 Jan; 41(1):21-31. PubMed ID: 20708623
[TBL] [Abstract][Full Text] [Related]
6. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
7. Co-infection with Trypanosoma cruzi protects mice against early death by neurological or pulmonary disorders induced by Plasmodium berghei ANKA.
Egima CM; Macedo SF; Sasso GR; Covarrubias C; Cortez M; Maeda FY; Costa FT; Yoshida N
Malar J; 2007 Jul; 6():90. PubMed ID: 17620126
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Plasmodium berghei parasitemia by LiCl in an animal infection model.
Nurul Aiezzah Z; Noor E; Hasidah MS
Trop Biomed; 2010 Dec; 27(3):624-31. PubMed ID: 21399604
[TBL] [Abstract][Full Text] [Related]
9. MDR1A (ABCB1)-deficient CF-1 mutant mice are susceptible to cerebral malaria induced by Plasmodium berghei ANKA.
de Lagerie SB; Fernandez C; German-Fattal M; Gantier JC; Gimenez F; Farinotti R
J Parasitol; 2008 Oct; 94(5):1139-42. PubMed ID: 18973419
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 Treatment Induces an Experimental Cerebral Malaria-Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65.
Martins YC; Freeman BD; Akide Ndunge OB; Weiss LM; Tanowitz HB; Desruisseaux MS
Am J Pathol; 2016 Nov; 186(11):2957-2969. PubMed ID: 27640146
[TBL] [Abstract][Full Text] [Related]
11. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.
Miranda AS; Brant F; Rocha NP; Cisalpino D; Rodrigues DH; Souza DG; Machado FS; Rachid MA; Teixeira AL; Campos AC
Malar J; 2013 Nov; 12():388. PubMed ID: 24180288
[TBL] [Abstract][Full Text] [Related]
12. VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria.
Canavese M; Dottorini T; Crisanti A
Pathog Glob Health; 2015 Sep; 109(6):255-65. PubMed ID: 26392042
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles derived from plasmodium-infected red blood cells alleviate cerebral malaria in plasmodium berghei ANKA-infected C57BL/6J mice.
Lv Y; Wu S; Nie Q; Liu S; Xu W; Chen G; Du Y; Chen J
Int Immunopharmacol; 2024 May; 132():111982. PubMed ID: 38569430
[TBL] [Abstract][Full Text] [Related]
14. Neuroimmunological blood brain barrier opening in experimental cerebral malaria.
Nacer A; Movila A; Baer K; Mikolajczak SA; Kappe SH; Frevert U
PLoS Pathog; 2012; 8(10):e1002982. PubMed ID: 23133375
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
Odhiambo OC; Wamakima HN; Magoma GN; Kirira PG; Malala BJ; Kimani FT; Muregi FW
Malar J; 2017 Jul; 16(1):268. PubMed ID: 28673299
[TBL] [Abstract][Full Text] [Related]
16. Oral Therapy Using a Combination of Nanotized Antimalarials and Immunomodulatory Molecules Reduces Inflammation and Prevents Parasite Induced Pathology in the Brain and Spleen of
Mukherjee S; Ray G; Saha B; Kar SK
Front Immunol; 2021; 12():819469. PubMed ID: 35095923
[TBL] [Abstract][Full Text] [Related]
17. Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection.
Apoorv TS; Babu PP
Cytokine; 2017 Feb; 90():113-123. PubMed ID: 27865203
[TBL] [Abstract][Full Text] [Related]
18. Phenylhydrazine administration accelerates the development of experimental cerebral malaria.
Zhu X; Liu J; Feng Y; Pang W; Qi Z; Jiang Y; Shang H; Cao Y
Exp Parasitol; 2015 Sep; 156():1-11. PubMed ID: 26005191
[TBL] [Abstract][Full Text] [Related]
19. Effect of α-Tocopheryloxy Acetic Acid on the Infection of Mice with Plasmodium berghei ANKA In Vivo and Humans with P. falciparum In Vitro.
Ariefta NR; Kume A; Nishikawa Y; Taniguchi T; Umemiya-Shirafuji R; Kasai S; Suzuki H
Acta Parasitol; 2022 Dec; 67(4):1514-1520. PubMed ID: 35951222
[TBL] [Abstract][Full Text] [Related]
20. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice.
Neill AL; Hunt NH
Parasitology; 1992 Oct; 105 ( Pt 2)():165-75. PubMed ID: 1280805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
